Volkmann Introduces Low-Profile Pneumatic Conveyor - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Volkmann Introduces Low-Profile Pneumatic Conveyor

Equipment and Processing Report

Low-profile models in Volkmann’s pneumatic pharmaceutical conveyor series (PPCVS) feature a low-profile vacuum pump and reverse-jet shock tank to convey tablets and capsules in restricted height areas. All Volkmann PPCVS units feature a one-piece, gap-free design with a smooth, polished stainless-steel surface. A modular, quick-release, cGMP design allows for no-tools cleaning. The units feature a patented QX filter system with a unique connection to the filter plate. In this design, a double seal replaces the commonly used felt seal or O-ring seal and ensures complete isolation of the process down to 0.3 micron.

Source: Volkmann

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Equipment and Processing Report,
Click here